Immunotherapy for Cancer

By Jimc | Jimc created a magazine on Flipboard. “Immunotherapy for Cancer on Flipboard” is available with thousands of other magazines and all the news you care about. Download Flipboard for free and search for “Jimc”.

Doctors Said Immunotherapy Would Not Cure Her Cancer. They Were Wrong.

No one expected the four young women to live much longer. They had an extremely rare, aggressive and fatal form of ovarian cancer. There was no standard treatment.<p>The women, strangers to one another living in different countries, asked their doctors to try new immunotherapy drugs that had …

Cancer

Immunotherapy in CRC Depends on Identifying Predictive Biomarkers

Dung Thi Le, MD<p>Even as immunotherapy grows more popular as a treatment for solid tumors, physicians are racing to identify patients with the …

Immunotherapy

Implications of Recent Data from CheckMate-142 in CRC

Breast Cancer<p>Multiple Myeloma<p>Lung Cancer<p>Immuno-Oncology News<p>Gynecologic Oncology<p>Gastrointestinal Cancer<p>Colorectal Cancer<p>Ovarian Cancer<p>Prostate …

Cancer

Why immunotherapies are the great hope in cancer medicine

As Tessa Jowell and Nicola Mendelsohn speak out about their need for immunotherapy, Ross Lydall investigates a 'sea change' for cancer treatment

Cancer

Medscape Log In

Medscape

Bristol-Myers talks up lung cancer data

Dive Brief:<p>Along with full-year earnings, Bristol-Myers Squibb Company announced positive topline results for its CheckMate-227 trial in the …

Cancer ‘vaccine’ eliminates tumors in mice

Activating T cells in tumors eliminated even distant metastases in mice, Stanford researchers found. Lymphoma patients are being recruited to test …

Immunotherapy

Weber Shares Insight on Future of Immunotherapy in Melanoma

There is an ipilimumab-plus-nivolumab-plus-epacadostat trial going on—so the sky is the limit—and if you can flip the doses and arrange the schedule …

Immunotherapy

Isolated immune-related pancreatic exocrine insufficiency associated with pembrolizumab therapy | Immunotherapy

*Author for correspondence: Tel.: +61 285 140 000;<p>Chris O'Brien Lifehouse, Medical Oncology Department, Camperdown, NSW, Australia<p>Royal Prince Alfred …

Immunotherapy

Napabucasin Plus Pembrolizumab Shows Early Promise in mCRC

Combining the investigational oral cancer stem cell pathway inhibitor napabucasin with the PD-1 inhibitor pembrolizumab showed a signal of efficacy …

Cancer

Dr. Overman on Updated Findings With Nivolumab in Metastatic CRC

Breast Cancer<p>Multiple Myeloma<p>Lung Cancer<p>Immuno-Oncology News<p>Gynecologic Oncology<p>Gastrointestinal Cancer<p>Colorectal Cancer<p>Ovarian Cancer<p>Prostate …

Cancer

For Cancer Patients, ImmunoMap Tracks Immunotherapy Responses

Scientists at Johns Hopkins have created a digital map that addresses the variability of T-cell receptors, the chemical “antennas” that recognize …

Immunotherapy Progress in the Treatment of CRC

John L. Marshall, MD, chief, Division of Hematology/Oncology, Medstar Georgetown University Hospital, director, Otto J. Ruesch Center for the Cure of …

Merck's KEYTRUDA(R) (pembrolizumab) Significantly Improved Overall Survival and Progression-Free Survival as First-Line Treatment in Combination with Pemetrexed and Platinum Chemotherapy for Patients with Metastatic Nonsquamous Non-Small Cell Lung Cancer

Details<p>Category: Antibodies<p>Hits: 296<p><i>KEYTRUDA is First PD1 Inhibitor in Combination to Show Overall Survival in NSCLC</i><p><b>KENILWORTH, NJ, USA I January 16,</b> …

Cancer

Immuno-oncology Experts Inonvio and Parker Form Bladder Cancer Therapy Partnership

Inovio Pharmaceuticals and the Parker Institute for Cancer Immunotherapy will collaborate on combination therapies for muscle-invasive bladder cancer.<p>…

Dr. Plimack on Choosing a Checkpoint Inhibitor in Bladder Cancer

Breast Cancer<p>Multiple Myeloma<p>Lung Cancer<p>Immuno-Oncology News<p>Gynecologic Oncology<p>Gastrointestinal Cancer<p>Colorectal Cancer<p>Ovarian Cancer<p>Prostate …

Cancer

The Inside Story Of A Major Medical Breakthrough

Innovation is never a single event<p>When Jim Allison received a call from Dr. Jedd Wolchok, asking him to come to his office, he was puzzled at first. As a researcher, he rarely ventured into the clinical part of the hospital. Yet when he opened the door and saw his colleague sitting with a young …

Cancer

Infographic: What Are Checkpoint Inhibitors and How Do They Fight Cancer?

<b>Everything you need to know about what checkpoint inhibitors are and why they have caused a wave of hype for cancer immunotherapies.</b><p>Since the …

Cancer

McDermott Shares Insight on Immunotherapy in RCC

We are getting a glimpse that perhaps when you combine several aspects of the tumor into a model, that you could better predict who can receive …

Pembrolizumab May Cure Metastatic Melanoma in A Subset of Patients

January 02, 2018<p>Share this content:<p>Baseline tumor size and PD-L1 status were independently associated with the likelihood of a complete …

The Biggest Cancer News Of 2017? 'CAR-T Cells, Hands Down'

Support the news<p>As 2017 and our series, "This Moment In Cancer," draw to a close, I asked a handful of local experts: What was the biggest cancer …

2017 Therapeutic Advancements in Oncology

Browse by Series:<p>Gina Columbus<p><b>Published Online:</b> Wednesday, Dec 27, 2017<p>Today-<p>We are reflecting on the top 10 advances in oncology throughout …

Understanding the Memory of the Immune System

Our immune system has an incredible ability; it can remember infections it has already encountered, and when the body has another encounter with the …

WOW! A Quick Guide to Understanding FDA's Keytruda Approval

Posted by Kathleen Hoffman on May 26, 2017 in Blog | 0 comments<p>In July 2015, we published a post called Patients Included In Research: Studying …

Immune System

3 Promising Cancer Immunotherapies to Watch in 2018

Bristol-Myers Squibb, Incyte, and Nektar Therapeutics could provide the biggest fireworks next year on the immunotherapy scene.<p>Any way you look at …

Frontline Findings Put Fresh Focus on Immunotherapy in NSCLC

Solange Peters, MD, PhD<p>Findings from the phase III IMpower150 study have placed renewed focus on the optimal role for immunotherapy in the frontline …

Key to immune system’s memory revealed

Monash University scientists have defined a novel molecular ‘blueprint’ that plays a pivotal part in the immune system’s ability to fight disease by …

Dr. Bendell Discusses Pembrolizumab in CRC